Autoimmunity and malaria: What are they doing together?

Acta Tropica

Volumn 76, Issue 3, 2000, Pages 205-221

  Daniel Ribeiro, Cláudio T ^a   Zanini, Graziela ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Autoantibodies (AAb); Autoimmune diseases (AID); Autoimmunity; Cross reactions; Immune protection; Malaria; Plasmodium; Premunition; Vaccination

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNITY; CROSS REACTION; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MALARIA; NONHUMAN; PLASMODIUM; REVIEW; VACCINATION;

EID: 0034597384     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(00)00099-1     Document Type: Article

References (110)

1. Abu-Shakra M., Schoenfeld Y. Parasitic infection and autoimmunity. Autoimmunity. 9:1991;337-344.
2. Adebajo A.O. Does tumor necrosis factor protect against lupus in west Africans? Arthritis Rheum. 35:1992;839.
3. Adebajo A.O., Charles P., Maini R.N., Hazleman B.L. Autoantibodies in malaria, tuberculosis and hepatitis B in west African population. Clin. Exp. Immunol. 92:1993;73-76.
4. Adu D., Gwynwilliams D., Quakyi I.A. et al. Anti-ssDNA and antinuclear antibodies in human malaria. Clin. Exp. Immunol. 49:1982;310-316.
5. Bach J.F. La reconnaissance du soi et ses dérèglements: maladies auto-immunes, auto-immunité physiologique et pathologique. Bach J.F. Traité d'Immunologie: Flammarion Médécine-Sciences-Paris. 1993;751-786.
6. Baldé A.T., Sarthou J-L., Rousilhon C. Acute Plasmodium falciparum infection is associated with increased percentages of apoptotic cells. Immunol. Lett. 46:1995;59-62.
7. Banic D.M., Viana-Martins F.S., De Souza J.M., Peixoto T.C., Daniel-Ribeiro C.T. Polyclonal B-lymphocyte stimulation in human malaria and its association with ongoing parasitemia. Am. J. Trop. Med. Hyg. 44:1991;571-577.
8. Bate C.A.W., Taverne J., Bootsma H.J. et al. Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology. 76:1992;35-41.
9. Bate C.A.W., Taverne J., Roman E, Moreno C., Playfair J.H.L. TNF induction by malaria exoantigens depends upon phospholipid. Immunology. 75:1992;129-135.
10. Ben-Slama, L., 1982. L'auto-immunité dans le paludisme: étude de la fréquence des auto-anticorps anti-noyaux et anti muscle lisse en fonction du degré d'immunité antipaludéene. Thése de Doctorat en Médecine, Faculté de Médecine Pitié SalpétrièreUniversité de Paris VI.
11. Bonfa E, Llovet R., Scheinberg M., De Souza J.M. Comparison between autoantibodies in malaria and leprosy with lupus. Clin. Exp. Immunol. 70:1987;529-537.
12. Boonpucknavig S., Ekapanyakul G. Autoantibodies in sera of Thai patients with Plasmodium falciparum infection. Clin. Exp. Immunol. 58:1984;77-82.
13. Bordmann G., Rudin W., Favre N. Immunization of mice with phosphatidylcholine drastically reduces the parasitaemia of subsequent Plasmodium chabaudi blood-stage infections. Immunology. 94:1998;35-40.
14. Burger-Rolland L., Ballet J.J., Daniel-Ribeiro C.T. Kinetics of antigen specific and non-specific polyclonal B-cell responses during lethal P. yoelii malaria. Mem. I. Oswaldo Cruz. 87:1992;197-204.
15. Butcher G.A., Clark I.A. SLE and malaria: another look at an old idea. Parasitol. Today. 6:1990;259-261.
16. Butcher G.A. Does malaria select for predisposition to auto-immune disease? J. Roy. Soc. Med. 84:1991;451-453.
17. Capron A., Biguet J., Vernes A., Afchain D. Structure antigénique des helminthes. Aspects immunologiques des relations hôte-parasite. Pathol. Biol. 16:1968;165-173.
18. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus, erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1994;1317-1330.
19. Clark I.A., Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoesis and erythrophagocytosis. Br. J. Haemat. 70:1988;99-103.
20. Colaço C.B., Male D.K. Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity. Clin. Exp. Immunol. 59:1985;449-456.
21. Coutinho A., Kazatchkine M.D., Avrameas S. Natural autoantibodies. Curr. Opin. Immunol. 7:1995;812-818.
22. Cunningham A.J. Self-tolerance maintained by active suppressor mechanisms. Transplant. Rev. 31:1976;23-43.
23. Damian R.T. Molecular mimicry: antigen sharing by parasite and host and its consequences. Am. Nat. 98:1964;129-149.
24. Daniel-Ribeiro, C.T., Monjour, L., Pontes-de-Carvalho, L.C., Playfair, J.H.L, Gentilini, M., 1982. Malaria infection and simultaneous administration of mouse thyroglobulin induce a specific autoimmune response in mice. Mol. Biochem. Parasitol. Suppl., 365-366.
25. Daniel-Ribeiro C.T., Druilhe R, Monjour L., Homberg J.C., Gentilini M. Specificity of autoantibodies in malaria and the role of polyclonal activation. Trans. R. Soc. Trop. Med. Hyg. 77:1983;185-188.
26. Daniel-Ribeiro C.T., Alfred C., Monjour L., Gentilini M. Normal frequency of anti-thyroglobulin antibodies in hyperendemic areas of malaria: relevance to the understanding of auto-antibody formation in Malaria. Trop. Geogr. Med. 36:1984;323-328.
27. Daniel-Ribeiro C.T., de Roquefeuil S., Druilhe P., Monjour L., Homberg J.C., Gentilini M. Abnormal anti single-stranded activity in sera from Plasmodium falciparum infected individuals. Trans. R. Soc. Trop. Med. Hyg. 78:1984;742-746.
28. Daniel-Ribeiro C.T., Kalil J., Monjour L., Alfred C., Ploton I., Gentilini M. Cross reactions between Plasmodium falciparum and mammalian tissue antigens detected by monoclonal antibodies. Ann. Trop. Med. Parasitol. 78:1984;75-76.
29. Daniel-Ribeiro C.T., Banic D.M., Ahmed I.I., Galvão-Castro B. Polyclonal B-lymphocyte activation and sensitization of erythrocytes by IgG in human malaria relevance to the development of anaemia in a holoendemic area in northwestern Brazil (Ariquemes-Rondônia). Mem. I. Oswaldo Cruz. 81:1986;169-176.
30. Daniel-Ribeiro C.T. Polyclonal B-cell activation: what have we learned from the study of malaria? Mem. I. Oswaldo Cruz. 83:1988;633-648.
31. Daniel-Ribeiro C.T., Ben-Slama L., Gentilini M. Anti-nuclear and anti-smooth muscle antibodies in Caucasians, Africans and Asians with acute malaria. J. Clin. Lab. Immunol. 35:1991;109-112.
32. Daniel-Ribeiro C.T., Deslandes D., Ferreira-Da-Cruz M.F. Cross-reactions between idiotypes, Plasmodium falciparum derived peptides, dinitrophenyl and B(2-6) polyfructosan. J. Clin. Lab. Immunol. 36:1991;23-26.
33. Daniel-Ribeiro C.T Is there a role for autoimmunity in immune protection against malaria? Mem. I. Oswaldo Cruz. 95:2000;199-207.
34. Dayer J.M., Fenner H. The role of cytokines and their inhibitors in arthritis. Baillières Clin. Rheumatol. 36:1992;901.
35. De Souza J.B., Playfair J.H.L. Anti-lymphocyte autoantibody in lethal malaria and its suppression by non lethal malaria. Parasite Immunol. 5:1983;257-265.
36. Dighiero G., Guilbert B., Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. II: high incidence of monoclonal Ig exhibiting activity against actin and tubulin and sharing antibody specificities with natural antibodies. J. Immunol. 128:1982;2788-2792.
37. Dighiero G., Guilbert B., Fermant J.P., Lymberi P., Danon F., Avrameas S. Thirty-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglobulin and native DNA: immunologic studies and clinical correlations. Blood. 62:1983;264-270.
38. Dighiero G. Natural autoantibodies, tolerance and autoimmunity. Ann. NY Acad. Sci. 815:1997;182-192.
39. Doolan D.L., Hoffman S.L. IL-12 and NK cells are required for antigen-specific adaptative immunity against malaria initiated by CD8 T cells in the Plasmodium yoelii model. J. Immunol. 163:1999;884-892.
40. Ehrlich P., Morgenroth J. Ueber Haemolysine. Berl. Klin. Wochenschr. 37:1900;453-458.
41. Emlem W., Niebur J., Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152:1994;3685-3692.
42. Facer C.A., Agiostratidou G. High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria. Clin. Exp. Immunol. 95:1994;304-309.
43. Facer C.A., Bray R.S., Brown J. Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria: incidence and class specificity. Clin. Exp. Immunol. 35:1979;119-127.
44. Facer C.A. Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria II: specificitv of erythrocyte-bound IgG. Clin. Exp. Immunol. 39:1980;279-288.
45. Fawcett P.T., Fawcett L.B., Doughty R.A., Coleman R.M. Suppression of malaria-induced auto-immunity by immunization with cryoglobulins. Cell. Immunol. 118:1989;192-198.
46. Freeman R.R., Parish C.R. Polyclonal B-Cell activation during rodent malarial infections. Clin. Exp. Immunol. 32:1978;41-45.
47. Greenwood B.M. Auto immune disease and parasitic infections in Nigerians. Lancet. 1:1968;380-382.
48. Greenwood B.M., Herrick E.M., Holborow E.J. Speckled antinuclear factor in African sera. Clin. Exp. Immunol. 7:1970;75-83.
49. Greenwood B., Herrick E.M., Voller A. Suppression of auto-immune disease in NZB and (NZB×NZW) F1 hybrid mice by infection with malaria. Nature. 226:1970;266-267.
50. Greenwood B.M., Vick R.M. Evidence for a malaria mitogen in human malaria. Nature. 257:1975;592-594.
51. Guilbert B., Dighiero G., Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. I: detection, isolation and characterization. J. Immunol. 128:1982;2779-2787.
52. Hahn B.H. Antibodies to DNA. New England J. Med. 338:1998;1359-1368.
53. Hammarström L., Smith E., Primi D., Möller G. Induction of autoantibodies to red blood cells by polyclonal B-cell activators. Nature. 263:1976;60-61.
54. Hentati B., Sato M.N., Payelle-Brogard B., Avrameas S., Terrynck T. Beneficial effect of polyclonal immunoglobulins from malaria infected Balb/c mice on the lupus-like syndrome of (NZB×NZW) F1 mice. Eur. J. Immunol. 24:1994;8-15.
55. Hogh B., Petersen E., Crandall I., Gottschau A., Sherman I.W. Immune responses to band 3 neoantigens on Plasmodium falciparum-infected erythrocytes in subjects living in an area of intense malaria transmission are associated with low parasite density and high hematocrite value. Infect. Immun. 62:1994;4362-4366.
56. Houba V. Immunological aspects of renal lesions associated with malaria. Kidney Int. 16:1979;3-8.
57. Houba V., Prague M.D., Allison A.C. M-antiglobulins (rheumatoid-factor-like globulins) and other gamma-globulins in relation to tropical parasitic infections. Lancet. 6:1966;848-851.
58. Horowitz D.A., Gray J.D., Ohtsuka K., Hirokawa M., Takahashi T. The immunoregulatory effects of NK cells: the role of TGF-β and implications for autoimmunity. Immunol. Today. 18:1997;538-542.
59. Hunt J.E., McNeil H.P., Morgan G.J., Crameri R.M., Krillis S.A. A phospholipid-beta-2-glycoprotein 1 complex is an antigen for anticardiolipin antibodies occurring in auto-immune disease but not with infection. Lupus. 1:1992;75-81.
60. Izui S., Lambert P.H., Miescher P.A. In vitro demonstration of particular affinity of glomerular basement membrane and collagen for DNA: a possible basis for local formation of DNA-antiDNA complexes in systemic lupus erythematosus. J. Exp. Med. 144:1976;428-443.
61. Jacob C.O., McDevitt H.O. Tumour necrosis factor-α in murine auto-immune 'lupus' nephritis. Nature. 331:1988;356-358.
62. Jacob C.O. Tumor necrosis factor-α in auto-immunity: pretty girl or old witch? Immunol. Today. 13:1992;122-125.
63. Jarra W. Protective immunity to malaria and anti-erythrocyte autoimmunity. Ciba F. Symp. 94:1983;137-158.
64. Jayawardena A.N., Janeway C.A. Jr., Kem J.D. Experimental malaria in the CBA/N mouse. J. Immunol. 123:1979;2532-2539.
65. Kataaha P.K., Facer C.A., Mortazavi-Milani S.M., Stierle H., Holborow E.J. Stimulation of autoantibody production in normal blood lymphocytes by malaria culture supernatants. Parasite Immunol. 6:1984;481-492.
66. Kitaguchi T., Nagoya M., Amano T., Suzuki M., Minami M. Analysis of roles of natural killer cells in defence against Plasmodium chaubaudi in mice. Parasitol. Res. 82:1996;352-357.
67. Klareskog L., McDevitt H. Rheumatoid arthritis and its animal modes: the role of TNF-α and the possible absence of specific immune reactions. Curr. Opin. Immunol. 11:1999;657-662.
68. Kreier J.P., Dilley D.A. Plasmodium berghei: nucleic acid agglutinating antibodies in rats. Exp. Parasitol. 26:1969;175-180.
69. Kubata B.K., Eguchi N., Urade Y. et al. Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in human. J. Exp. Med. 188:1998;1197-1202.
70. Kwiatkowski M.D., Bate C.A.W., Scragg I.G., Beattie P., Udalova I., Knight J.C. The malarial fever response - pathogenesis, polymorphism and prospects for intervention. Ann. Trop. Med. Parasitol. 91:1997;533-542.
71. Lambert P.H., Goldman M., Rose L.M., Morel P.A. A possible role for idiotypic interactions in the pathogenesis of immune complex glomerulonephritis. Transplant. Proc. 14:1982;543-546.
72. Lefrançois G., Bouvet E., Le Bras J., Vroklans M., Simonneau M., Vachon F. Anti-erythrocyte autoimmunisation duning chronic falciparum malaria. Lancet. 2:1981;661-664.
73. Lloyd C.M., Collins I., Belcher A.J., Manuelpillai N., Wozencraft A.O., Staines N.A. Characterization and pathological significance of monoclonal DNA-binding antibodies from mice with experimental malaria infection. Infect. Immun. 62:1994;1982-1988.
74. Maini R.N., Breedveld F.C., Kalden J.R. et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 41:1998;1552-1563.
75. Mattei D., Scherf A. Cross-reacting epitopes shared between Plasmodium falciparum and its host: the origin of autoreactive antibodies? Res. Immunol. 142:1991;698-703.
76. McGuire W., Hill A.V.S., Allsopp C.E.M., Greenwood B.M., Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-511.
77. Merovac D., Chu J-L., Song X., Elkon K.B. Intravenous immunisation of mice with syngenic apoptotic cells induces autoantibodies. Arthritis Rheum. 49(Suppl 9):1997;S257.
78. Mori H., Natarajan K., Betschart B., Weiss N., Franklin R.M. Polyclonal B-cell activation and autoantibody formation during the course of mosquito-transmitted Plasmodium berghei infection in mice. Trop. Med. Parasit. 38:1987;157-162.
79. Pakasa M., Van Damme B., Desmet V.J. Free intraglomerular antigens. Br. J. Exp. Pathol. 66:1985;493-501.
80. Perlman P., Perlman H., Berzins K., Troye-Blomberg M. Selected problems of malaria blood stage immunity. Tokai J. Exp. Med. 23:1998;55-62.
81. Phanuphak P., Tirawatnpong S., Hanvanich M. et al. Autoantibodies in falciparum malaria: a sequential study in 183 Thai patients. Clin. Exp. Immunol. 53:1983;627-633.
82. Poels L.G., Van Niekerk C.C., Van der Sterren-Reti V., Jerusalem C. Plasmodium berghei: T-cell-dependent auto-immunity. Exp. Parasitol. 49:1980;97-105.
83. Quakyi I.A., Voller A., Hall A.P., Johnson G.D., Holborow D.J., Moody A.H. Immunological abnormalities in Caucasians with malaria. Immunol. Lett. 1:1979;153-154.
84. Richaud-Patin Y., Alcocer-Varela J., Llorente L. High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev. Invest. Clin. 47:1995;267-272.
85. Ritter K., Kuhlencord A., Thomssen R., Bommer W Prolonged haemolytic anaemia in malaria and autoantibodies against tniosephosphatase isomerase. Lancet. 342:1993;1333-1334.
86. Rizzo L.V., Dekruyff R.H., Umetsu D.T. Generation of B cell memory and affinity maturation. J. Immunol. 148:1992;3733-3739.
87. Roitt I.M., Doniach D., Campbell P., Hudson R.V. Auto-antibodies in Hashimoto's disease (lymphodenoid goiter). Lancet. 2:1956;820-821.
88. Roitt I.M. Autoimmune disease I - scope and aetiology. Roitt I.M. Essential Immunology. 1988;238-253 Blackwell Scientific Publications, London.
89. Rosenberg Y. Autoimmune and polyclonal B cell responses during murine malaria. Nature. 274:1978;170-172.
90. Rowe J.A., Scragg I.G., Kwiatkowski D., Ferguson D.J.P., Carucci D.J., Newbold C.I. Implications of mycoplasma contamination in Plasmodium falciparum cultures and methods for its detection and eradication. Mol. Bio. Parasitol. 92:1998;177-180.
91. Sayles P.C., Wassom D.L. Are antibodies important in mice infected with Plasmodium yoelii? Parasitol. Today. 8:1992;368-370.
92. Schetters T.P.M., Van Run-Van Breda J.H.J., Hermsen C., Curfs J., Eling W.M.C. Protective and pathological activity in serum of mice developing resistance to Plasmodium berghei infection. Parasite Immunol. 11:1989;413-423.
93. Shaper A.G., Kaplan M.H., Mody N.J., McIntyre P.A. Malarial antibodies and autoantibodies to heart and other tissues in the immigrant and indigenous peoples of Uganda. Lancet. 1:1968;1342-1347.
94. Sidman C.L., Shultz L.D., Hardy R.R., Hayakawa K., Herzenberg L.A. Production of immunoglobulin isotypes by Ly-l+ B cells in viable motheaten and normal mice. Science. 232:1986;1423-1425.
95. Singh V.K., Mehrotra S., Agarwal S.S. The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol. Res. 20:1999;147-161.
96. Sorensen P.G., Mickley H., Schmidt K.G. Malaria-induced immune thiombocytopenia. Vox Sang. 47:1984;68-72.
97. Souza-Passos L.F. Apoptosis and SLE: another piece in the puzzle? Rev. Bras. Reumatol. 37:1997;327-334.
98. Symmons D.P. Frequency of lupus in people of African origin. Lupus. 4:1995;176-178.
99. Taliaferro W.T., Cannon P.R. The cellular reactions during primary infections and superinfections of Plasmodium brasilianum in Panamanian monkeys. J. Infect. Dis. 59:1936;72-125.
100. Ternynck T., Falanga P.B., Unterkirscher C., Gregoire J., Da-Silva L.P., Avrameas S. Induction of high levels of IgG autoantibodies in mice infected with P. chabaudi. Int. Immunol. 3:1991;29-37.
101. Tsega E., Choremi H., Bottazzo G.F., Doniach D. Prevalence of autoimmune disease and autoantibodies in Ethiopia. Trop. Geogr. Med. 32:1980;231-236.
102. Van Damme B.J., Fleuren G.J., Bakker W.W., Vernier R.L., Hoedemaeker P.J. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V: fixed glomerular antigens in the pathogenisis of heterologous immune complex glomerulonephritis. Lab. Invest. 38:1978;502-510.
103. Voller A., O'Neill P., Humphrey D. Serological indices in Tanzania - II: antinuclear factor and malaria indices in populations living at different altitudes. J. Trop. Med. Hyg. 75:1972;136-139.
104. Woodruff A.W., Andsell V.E., Pettitt L.E. Cause of anaemia in malaria. Lancet. 19:1979;1055-1057.
105. Wozencraft A.O., Lloyd C.M., Staines N.A., Griffths V.J. Role of DNA-binding antibodies in kidney pathology associated with munine malaria infections. Infect. Immun. 58:1990;2156-2164.
106. Yahia T.M., Benedict S., Shalabi A, Bayoumi R Anti-neutrophil cytoplasmatic antibody (ANCA) in malaria is directed against cathepsin G. Clin Exp. Immunol. 110:1997;41-44.
107. Zouali M., Druilhe P., Gentilini M., Eyquem A High titres of anti-T antibodies and of other haemagglutinins in human malaria. Clin. Exp. Immunol. 50:1982;83-91.
108. Zouali M., Druilhe P., Eyquem A IgG-subclass expression of anti-DNA and anti nibonucleoprotein autoantibodies in human malaria. Clin. Exp. Immunol. 66:1986;273-278.
109. Zoutendyk A. Auto-antibodies in South African whites, coloured and Bantu. S. Afr. Med. J. 44:1970;469-470.
110. Zuckerman A. Autoimmunization and other types of indirect damage to host cells as factor in certain protozoan diseases. Exp. Parasitol. 15:1964;138-183.